Baillie Gifford other Recursion Pharmaceuticals, Inc.
Baillie Gifford other $199.4M of disclosed value in Recursion Pharmaceuticals, Inc..
Signal
Investor Move
Action
Other
Capital
$199.4M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.